EUROPE LIQUID BIOPSY MARKET 2019-2027

Lifesciences | Diagnostic & Biotechnology

EUROPE LIQUID BIOPSY MARKET 2019-2027

Market By Therapeutic Application, Product, Analysis Purpose, End-user, Analysis Platform, Biomarker Type, Clinical Application And Geography | Forecast 2019-2027

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

Triton’s research on the Europe liquid biopsy market depicts that it will grow at a stable pace with a CAGR of 21.97% in terms of revenue during the forecast period 2019-2027.

The countries that have been analyzed in the European liquid biopsy market are:

•           The United Kingdom

•           France

•           Germany

•           Italy

•           Spain

•           Russia

•           Rest of Europe

Report scope can be customized per your requirements. Request For Customization

The usage of healthcare services in Europe is high among older individuals due to their susceptibility to diseases and infections. The trend analysis in this region points out that the per capita health expenditure on healthcare is higher among older people compared with other ages. In many western European countries, such as Ireland, Germany, Italy, the Netherlands and Denmark, point-of-care healthcare services and institutional long-term care services for older people are easily available. This helps the older people to opt for diagnostic tests (including biopsies) and treatments, taking care of factors such as ease of use, accessibility and affordability.

Numerous small-sized companies in the German market are developing potential liquid biopsy products. Acquisition of small companies by larger ones will increase the R&D investment, which can increase the product categories in the market. For instance, in May 2016, Siemens Healthineers acquired NEO New Oncology in Germany. The company is engaged in the development of NEOliquid, which a liquid biopsy test for analyzing the genomic profiles of solid tumours derived from simple blood samples. The acquisition helped Siemens Healthineers to enter the market and increase competitiveness.

I.M.S. Internazionale Medico Scientifica S.r.l. (IMS), is a medical device company that manufactures and distributes breast care devices, such as mammo diagnostics and biopsy imaging equipment. The company offers products such as tomosynthesis tomo or stereo biopsy, prone & upright mammography stereotactic and prone biopsy, digital mammography biopsy and prone, upright & lateral biopsy. It provides 3D imaging solutions. IMS collaborates with universities and hospital clinics for its research & development activities. The company markets its products through its authorized dealers. It has a presence in the US and Italy. IMS is headquartered in Sasso Marconi, Italy.


Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1.    EUROPE LIQUID BIOPSY MARKET - SUMMARY

2.    INDUSTRY OUTLOOK

2.1. MARKET DEFINITION

2.2. KEY INSIGHT

2.3. PORTER’S FIVE FORCES ANALYSIS

2.3.1.   THREAT OF NEW ENTRANTS

2.3.2.   THREAT OF SUBSTITUTES

2.3.3.   BARGAINING POWER OF BUYERS

2.3.4.   BARGAINING POWER OF SUPPLIERS

2.3.5.   THREAT OF RIVALRY

2.4. REGULATORY FRAMEWORK

2.5. KEY MARKET TRENDS

2.6. KEY LIQUID BIOPSY INITIATIVES

2.7. MARKET ATTRACTIVENESS INDEX

2.8. MARKET DRIVERS

2.8.1.   CANCER CASES IN OLDER POPULACE ARE SIGNIFICANTLY INCREASING

2.8.2.   DIAGNOSTIC CENTERS ARE IN DEMAND

2.8.3.   TISSUE/TUMOR-AGNOSTIC DRUGS USAGE ARE INCREASING

2.8.4.   RISE IN USAGE OF PRECISION MEDICINE

2.9. MARKET RESTRAINTS

2.9.1.   HIGH COST OF TEST

2.9.2.   LACK OF A CONSENSUS ON STANDARD OPERATING PROCEDURES (SOPs)

2.10.            MARKET OPPORTUNITIES

2.10.1.                ADVANCEMENT IN TECHNOLOGY

2.10.2.                RISING NUMBER OF CANCER PATIENTS

2.11.            MARKET CHALLENGES

2.11.1.                LACK OF REIMBURSEMENT

2.11.2.                SKILLED PROFESSIONALS ARE QUITE LESS IN NUMBER

3.    LIQUID BIOPSY MARKET OUTLOOK - BY THERAPEUTIC APPLICATION

3.1. PROSTATE CANCER

3.2. MELANOMA CANCER

3.3. BREAST CANCER

3.4. COLORECTAL CANCER

3.5. LUNG CANCER

3.6. OTHER TYPES OF CANCER

3.7. NON-ONCOLOGY APPLICATIONS

4.    LIQUID BIOPSY MARKET OUTLOOK - BY PRODUCT

4.1. CELL-FREE DNA (CFDNA)

4.2. CIRCULATING TUMOR CELLS (CTCS)

4.3. CIRCULATING TUMOR DNA (CTDNA)

4.4. EXTRACELLULAR VESICLES AND OTHERS

5.    LIQUID BIOPSY MARKET OUTLOOK - BY ANALYSIS PURPOSE

5.1. MONITORING

5.2. THERAPY GUIDANCE

5.3. EARLY DETECTION/SCREENING

5.4. DIAGNOSIS

6.    LIQUID BIOPSY MARKET OUTLOOK - BY END-USER

6.1. HOSPITALS

6.2. PHYSICIANS’ OFFICE LABORATORIES

6.3. CLINICAL DIAGNOSTIC LABORATORIES

7.    LIQUID BIOPSY MARKET OUTLOOK - BY ANALYSIS PLATFORM

7.1. MICROARRAY

7.2. NGS

7.3. PROTEOMICS

7.4. PCR

7.5. OTHER ANALYSIS PLATFORMS

8.    LIQUID BIOPSY MARKET OUTLOOK - BY BIOMARKER TYPE

8.1. NUCLEIC ACIDS

8.2. PROTEINS

8.3. EXTRACELLULAR VESICLES

8.4. CELLS

9.    LIQUID BIOPSY MARKET OUTLOOK - BY CLINICAL APPLICATION

9.1. TREATMENT MONITORING

9.2. PROGNOSIS & REOCCURRENCE MONITORING

9.3. TREATMENT SELECTION

9.4. DIAGNOSIS & SCREENING

10. LIQUID BIOPSY MARKET - REGIONAL OUTLOOK

10.1.            EUROPE

10.2.            COUNTRY ANALYSIS

10.2.1.1.   THE UNITED KINGDOM

10.2.1.2.   FRANCE

10.2.1.3.   GERMANY

10.2.1.4.   ITALY

10.2.1.5.   SPAIN

10.2.1.6.   RUSSIA

10.2.1.7.   REST OF EUROPE

11. COMPETITIVE LANDSCAPE

11.1.            AGILENT TECHNOLOGIES, INC.

11.2.            BOSTON SCIENTIFIC CORPORATION

11.3.            ARGON MEDICAL DEVICES, INC.

11.4.            B. BRAUN MELSUNGEN AG

11.5.            CINTEC MEDICAL LTD.

11.6.            ROCHE DIAGNOSTICS CORPORATION

11.7.            AD-TECH MEDICAL INSTRUMENT CORP.

11.8.            I.M.S. INTERNAZIONALE MEDICO SCIENTIFICA SRL

11.9.            QIAGEN N.V.

11.10.         BECTON, DICKINSON

11.11.         PLANMECA OY

11.12.         BIO-RAD LABORATORIES, INC.

11.13.         CARDINAL HEALTH, INC.

11.14.         COOK MEDICAL, INC.

11.15.         FISCHER MEDICAL TECHNOLOGIES LLC

11.16.         C. R. BARD, INC. (ACQUIRED BY BECTON, DICKINSON AND COMPANY)

12. RESEARCH METHODOLOGY & SCOPE

12.1.            RESEARCH SCOPE & DELIVERABLES

12.1.1.                OBJECTIVES OF STUDY

12.1.2.                SCOPE OF STUDY

12.2.            SOURCES OF DATA

12.2.1.                PRIMARY DATA SOURCES

12.2.2.                SECONDARY DATA SOURCES

12.3.            RESEARCH METHODOLOGY

12.3.1.                EVALUATION OF PROPOSED MARKET

12.3.2.                IDENTIFICATION OF DATA SOURCES

12.3.3.                ASSESSMENT OF MARKET DETERMINANTS

12.3.4.                DATA COLLECTION

12.3.5.                DATA VALIDATION & ANALYSIS

List of table

TABLE 1        EUROPE LIQUID BIOPSY MARKET 2019-2027 ($ MILLION)

TABLE 2        LIQUID BIOPSY BIOMARKER CLASSES

TABLE 3        EUROPE LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATION 2019-2027 ($ MILLION)

TABLE 4        EUROPE LIQUID BIOPSY MARKET BY PRODUCT 2019-2027 ($ MILLION)

TABLE 5        EUROPE LIQUID BIOPSY MARKET BY ANALYSIS PURPOSE 2019-2027 ($ MILLION)

TABLE 6        EUROPE LIQUID BIOPSY MARKET BY END-USER 2019-2027 ($ MILLION)

TABLE 7        EUROPE LIQUID BIOPSY MARKET BY ANALYSIS PLATFORM 2019-2027 ($ MILLION)

TABLE 8        ADVANTAGES OF DROPLET DIGITAL PCR FOR SINGLE-CELL ANALYSIS

TABLE 9        DROPLET DIGITAL PCR INDUSTRIES

TABLE 10      EUROPE LIQUID BIOPSY MARKET BY BIOMARKER TYPE 2019-2027 ($ MILLION)

TABLE 11      CELL DIFFERENTIATORS

TABLE 12      EUROPE LIQUID BIOPSY MARKET BY CLINICAL APPLICATION 2019-2027 ($ MILLION)

TABLE 13      EUROPE LIQUID BIOPSY MARKET BY COUNTRY 2019-2027 ($ MILLION)         

List of Figures

FIGURE 1      EUROPE LIQUID BIOPSY MARKET 2019-2027 ($ MILLION)

FIGURE 2      EUROPE LIQUID BIOPSY MARKET BY PROSTATE CANCER 2019-2027 ($ MILLION)

FIGURE 3      EUROPE LIQUID BIOPSY MARKET BY MELANOMA CANCER 2019-2027 ($ MILLION)

FIGURE 4      TYPES OF BREAST CANCER

FIGURE 5      EUROPE LIQUID BIOPSY MARKET BY BREAST CANCER 2019-2027 ($ MILLION)

FIGURE 6      EUROPE LIQUID BIOPSY MARKET BY COLORECTAL CANCER 2019-2027 ($ MILLION)

FIGURE 7      EUROPE LIQUID BIOPSY MARKET BY LUNG CANCER 2019-2027 ($ MILLION)

FIGURE 8      EUROPE LIQUID BIOPSY MARKET BY OTHER TYPES OF CANCER 2019-2027 ($ MILLION)

FIGURE 9      EUROPE LIQUID BIOPSY MARKET BY NON-ONCOLOGY APPLICATION 2019-2027 ($ MILLION)

FIGURE 10   EUROPE LIQUID BIOPSY MARKET BY CELL-FREE DNA (CFDNA) 2019-2027 ($ MILLION)

FIGURE 11   EUROPE LIQUID BIOPSY MARKET BY CIRCULATING TUMOR CELLS (CTCS) 2019-2027 ($ MILLION)

FIGURE 12   EUROPE LIQUID BIOPSY MARKET BY CIRCULATING TUMOR DNA (CTDNA) 2019-2027 ($ MILLION)

FIGURE 13   EUROPE LIQUID BIOPSY MARKET BY EXTRACELLULAR VESICLES AND OTHERS 2019-2027 ($ MILLION)

FIGURE 14   EUROPE LIQUID BIOPSY MARKET BY MONITORING 2019-2027 ($ MILLION)

FIGURE 15   EUROPE LIQUID BIOPSY MARKET BY THERAPY GUIDANCE 2019-2027 ($ MILLION)

FIGURE 16   EUROPE LIQUID BIOPSY MARKET BY EARLY DETECTION/SCREENING 2019-2027 ($ MILLION)

FIGURE 17   EUROPE LIQUID BIOPSY MARKET BY DIAGNOSIS 2019-2027 ($ MILLION)

FIGURE 18   EUROPE LIQUID BIOPSY MARKET BY HOSPITALS 2019-2027 ($ MILLION)

FIGURE 19   EUROPE LIQUID BIOPSY MARKET BY PHYSICIANS’ OFFICE LABORATORIES 2019-2027 ($ MILLION)

FIGURE 20   EUROPE LIQUID BIOPSY MARKET BY CLINICAL DIAGNOSTIC LABORATORIES 2019-2027 ($ MILLION)

FIGURE 21   EUROPE LIQUID BIOPSY MARKET BY MICROARRAY 2019-2027 ($ MILLION)

FIGURE 22   EUROPE LIQUID BIOPSY MARKET BY NGS 2019-2027 ($ MILLION)

FIGURE 23   EUROPE LIQUID BIOPSY MARKET BY PROTEOMICS 2019-2027 ($ MILLION)

FIGURE 24   EUROPE LIQUID BIOPSY MARKET BY PCR 2019-2027 ($ MILLION)

FIGURE 25   EUROPE LIQUID BIOPSY MARKET BY OTHER ANALYSIS PLATFORM 2019-2027 ($ MILLION)

FIGURE 26   EUROPE LIQUID BIOPSY MARKET BY NUCLEIC ACIDS 2019-2027 ($ MILLION)

FIGURE 27   EUROPE LIQUID BIOPSY MARKET BY PROTEINS 2019-2027 ($ MILLION)

FIGURE 28   EUROPE LIQUID BIOPSY MARKET BY EXTRACELLULAR VESICLES 2019-2027 ($ MILLION)

FIGURE 29   EUROPE LIQUID BIOPSY MARKET BY CELLS 2019-2027 ($ MILLION)

FIGURE 30   EUROPE LIQUID BIOPSY MARKET BY TREATMENT MONITORING 2019-2027 ($ MILLION)

FIGURE 31   EUROPE LIQUID BIOPSY MARKET BY PROGNOSIS & REOCCURRENCE MONITORING 2019-2027 ($ MILLION)

FIGURE 32   EUROPE LIQUID BIOPSY MARKET BY TREATMENT SELECTION 2019-2027 ($ MILLION)

FIGURE 33   EUROPE LIQUID BIOPSY MARKET BY DIAGNOSIS & SCREENING 2019-2027 ($ MILLION)

FIGURE 34   THE UNITED KINGDOM LIQUID BIOPSY MARKET 2019-2027 ($ MILLION)

FIGURE 35   FRANCE LIQUID BIOPSY MARKET 2019-2027 ($ MILLION)

FIGURE 36   GERMANY LIQUID BIOPSY MARKET 2019-2027 ($ MILLION)

FIGURE 37   ITALY LIQUID BIOPSY MARKET 2019-2027 ($ MILLION)

FIGURE 38   SPAIN LIQUID BIOPSY MARKET 2019-2027 ($ MILLION)

FIGURE 39   RUSSIA LIQUID BIOPSY MARKET 2019-2027 ($ MILLION)

FIGURE 40   REST OF EUROPE LIQUID BIOPSY MARKET 2019-2027 ($ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;